Stocktoria
Aura Biosciences, Inc. AURA
Nasdaq · XNAS · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2021-10-29
Aura Biosciences, Inc. insider transactions (Form 4)
| Insider | Role | Date | Action | Shares | Price |
|---|---|---|---|---|---|
| Gibney Anthony S | See Remarks | 2026-06-16 | Sell | 12,824 | $6.42 |
| Bitetti Teresa Marie | director | 2026-06-11 | Grant | 15,000 | — |
| Srivastava Sapna | director | 2026-06-11 | Grant | 15,000 | — |
| Johnson David Michael | director | 2026-06-11 | Grant | 15,000 | — |
| Mattessich Antony C. | director | 2026-06-11 | Grant | 15,000 | — |
| Holles Natalie C. | See Remarks | 2026-05-19 | Grant | 600,118 | — |
| Holles Natalie C. | See Remarks | 2026-05-19 | Grant | 553,844 | — |
| Matrix Capital Management Company, LP | 10% owner | 2026-05-07 | Sell | 6,922,870 | $5.64 |
Source: SEC EDGAR filings · CIK 0001501796 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.